

Improving the health of our patients through groundbreaking clinical research
The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.
Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).
Qualifications:
Duration: Up to 14 weeks
Location: Hackensack, NJ
Compensation: Up to $785
Interested in participating in our clinical research study? Please click here.
Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.
Qualifications:
Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed
To participate Please click here.
Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.
Qualifications:
Duration: 26 weeks/ visiting doctors office 10 to 12 times
Location: Hackensack, NJ
Compensation: If all visits are kept, up to $375 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.
Qualifications:
Duration: Up to 20 weeks
Location: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Purpose: To evaluate the clinical efficacy of SofWave treatment to improve acne scars appearance. Eligible patients will receive 3 treatments (4-6 weeks apart) on the facial acne scars using Sofwave System. All patients will return to the clinic for one follow up visit at 3 months post last treatment.
Qualifications:
Duration: Approx. 6 months
Location: Hackensack, NJ
Compensation: Up to $120 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Interested in participating in our clinical research study? Please click here.
To learn more contact: Diana Aranzazu, [email protected], 609-219-5621
All Rights Reserved. Web Design & Internet Marketing by Studio III
The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.
New safety policies for patients:
New safety policies for office & staff: